CCDC178
gene geneOn this page
Also known as FLJ44050
Summary
CCDC178 (coiled-coil domain containing 178, HGNC:29588) is a protein-coding gene on chromosome 18q12.1, encoding Coiled-coil domain-containing protein 178 (Q5BJE1). May play a crucial role in head shaping and sperm flagellum formation.
Located in ciliary basal body.
Source: NCBI Gene 374864 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 141 total
- MANE Select transcript:
NM_001105528
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29588 |
| Approved symbol | CCDC178 |
| Name | coiled-coil domain containing 178 |
| Location | 18q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ44050 |
| Ensembl gene | ENSG00000166960 |
| Ensembl biotype | protein_coding |
| OMIM | 621139 |
| Entrez | 374864 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 11 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000300227, ENST00000383096, ENST00000399177, ENST00000403303, ENST00000406524, ENST00000577268, ENST00000577766, ENST00000579916, ENST00000579947, ENST00000581524, ENST00000581852, ENST00000583550, ENST00000583930
RefSeq mRNA: 5 — MANE Select: NM_001105528
NM_001105528, NM_001308126, NM_001371120, NM_001371121, NM_198995
CCDS: CCDS11906, CCDS42424, CCDS77174
Canonical transcript exons
ENST00000383096 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001108200 | 33215550 | 33215695 |
| ENSE00001108209 | 33211896 | 33212055 |
| ENSE00001141952 | 33226793 | 33226855 |
| ENSE00001141975 | 33267202 | 33267297 |
| ENSE00001141987 | 33323491 | 33323633 |
| ENSE00001198459 | 33224775 | 33224936 |
| ENSE00001198470 | 33266916 | 33267052 |
| ENSE00001366990 | 33245245 | 33245428 |
| ENSE00001368226 | 33092761 | 33092910 |
| ENSE00001368996 | 33370050 | 33370189 |
| ENSE00001371533 | 33346211 | 33346411 |
| ENSE00001373942 | 33348890 | 33348975 |
| ENSE00001375105 | 33389540 | 33389629 |
| ENSE00001378954 | 33293159 | 33293312 |
| ENSE00001382109 | 33356324 | 33356346 |
| ENSE00001382818 | 33397149 | 33397208 |
| ENSE00001386372 | 33412031 | 33412110 |
| ENSE00001389125 | 32974547 | 32974681 |
| ENSE00001404301 | 33439962 | 33440081 |
| ENSE00001494848 | 33223106 | 33223219 |
| ENSE00001494884 | 33440653 | 33440721 |
| ENSE00002720405 | 32937406 | 32938091 |
| ENSE00003654283 | 33333174 | 33333394 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 92.54.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1311 / max 14.5812, expressed in 52 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 171609 | 0.0856 | 38 |
| 171610 | 0.0454 | 19 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 92.54 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.90 | gold quality |
| left testis | UBERON:0004533 | 82.67 | gold quality |
| right testis | UBERON:0004534 | 82.51 | gold quality |
| testis | UBERON:0000473 | 81.62 | gold quality |
| omental fat pad | UBERON:0010414 | 81.36 | gold quality |
| peritoneum | UBERON:0002358 | 81.25 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 81.07 | gold quality |
| adipose tissue | UBERON:0001013 | 78.38 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 77.90 | gold quality |
| spleen | UBERON:0002106 | 76.05 | gold quality |
| left ovary | UBERON:0002119 | 74.13 | gold quality |
| right ovary | UBERON:0002118 | 73.59 | gold quality |
| adrenal tissue | UBERON:0018303 | 70.85 | gold quality |
| parietal pleura | UBERON:0002400 | 70.42 | gold quality |
| endocervix | UBERON:0000458 | 70.06 | gold quality |
| ovary | UBERON:0000992 | 69.66 | gold quality |
| visceral pleura | UBERON:0002401 | 69.29 | gold quality |
| gall bladder | UBERON:0002110 | 69.15 | gold quality |
| ectocervix | UBERON:0012249 | 69.01 | gold quality |
| prostate gland | UBERON:0002367 | 68.97 | gold quality |
| tibial nerve | UBERON:0001323 | 68.35 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 68.10 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 66.96 | gold quality |
| buccal mucosa cell | CL:0002336 | 66.88 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 66.64 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 66.45 | gold quality |
| metanephros cortex | UBERON:0010533 | 66.35 | gold quality |
| mammary gland | UBERON:0001911 | 66.07 | gold quality |
| vagina | UBERON:0000996 | 64.78 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 31.77 |
| E-ANND-3 | yes | 4.89 |
| E-MTAB-6678 | no | 2.44 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
55 targeting CCDC178, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
| HSA-MIR-4470 | 99.66 | 69.35 | 1767 |
| HSA-MIR-378A-5P | 99.65 | 66.33 | 1311 |
| HSA-MIR-548AV-5P | 99.60 | 70.84 | 2107 |
| HSA-MIR-548K | 99.60 | 70.84 | 2107 |
| HSA-MIR-4310 | 99.59 | 68.84 | 2527 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-4677-3P | 99.49 | 67.91 | 1246 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-8054 | 99.48 | 70.81 | 2084 |
| HSA-MIR-766-3P | 99.47 | 65.24 | 1811 |
| HSA-MIR-582-5P | 99.47 | 70.79 | 2635 |
| HSA-MIR-578 | 99.46 | 68.36 | 1787 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-12113 | 99.32 | 67.54 | 1072 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-6799-5P | 99.14 | 65.72 | 2093 |
| HSA-MIR-3160-3P | 99.07 | 64.78 | 955 |
| HSA-MIR-4717-3P | 99.06 | 66.34 | 1072 |
| HSA-MIR-3164 | 99.02 | 68.39 | 1071 |
Literature-anchored findings (GeneRIF, showing 2)
- CCDC178 as a novel candidate oncogene involved in anoikis resistance and hepatocellular carcinoma (HCC) metastasis, and raise the possibility that CCDC178 may be a new therapeutic target for HCC. (PMID:28319061)
- Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178. (PMID:38358459)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccdc178 | ENSMUSG00000024306 |
| rattus_norvegicus | Ccdc178 | ENSRNOG00000022156 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 178 — Q5BJE1 (reviewed: Q5BJE1)
All UniProt accessions (7): Q5BJE1, A0A0A0MS97, F8W7A7, J3KRT5, J3KSU3, J3QKU2, J3QRM8
UniProt curated annotations — full annotation on UniProt →
Function. May play a crucial role in head shaping and sperm flagellum formation.
Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5BJE1-1 | 1 | yes |
| Q5BJE1-2 | 2 | |
| Q5BJE1-3 | 3 | |
| Q5BJE1-4 | 4 |
RefSeq proteins (5): NP_001098998, NP_001295055, NP_001358049, NP_001358050, NP_945346 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038826 | CCDC178 | Family |
UniProt features (16 total): sequence variant 5, coiled-coil region 4, sequence conflict 3, splice variant 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5BJE1-F1 | 76.69 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 70 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOCC_MICROTUBULE_ORGANIZING_CENTER, CATTTCA_MIR203, chr18q12, GTGTTGA_MIR505, GOCC_CENTROSOME, AAAGACA_MIR511, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, ATGTCAC_MIR489, GTCAGGA_MIR378, GTGACTT_MIR224, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, TGGAAA_NFAT_Q4_01, GOCC_CILIUM
GO Biological Process (2): spermatid development (GO:0007286), manchette assembly (GO:1905198)
GO Molecular Function (0):
GO Cellular Component (2): centrosome (GO:0005813), ciliary basal body (GO:0036064)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| microtubule organizing center | 2 |
| germ cell development | 1 |
| spermatid differentiation | 1 |
| spermatid development | 1 |
| cellular component assembly | 1 |
| centriole | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
364 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC178 | RMP24 | Q32NC0 | 507 |
| CCDC178 | CCDC167 | Q9P0B6 | 465 |
| CCDC178 | CCDC34 | Q96HJ3 | 453 |
| CCDC178 | GAREM1 | Q9H706 | 447 |
| CCDC178 | CCDC8 | Q9H0W5 | 447 |
| CCDC178 | OR5H1 | A6NKK0 | 447 |
| CCDC178 | CCDC106 | Q9BWC9 | 422 |
| CCDC178 | OR7E24 | Q6IFN5 | 397 |
| CCDC178 | RPRD1A | Q96P16 | 394 |
| CCDC178 | CCDC121 | Q6ZUS5 | 394 |
| CCDC178 | RTTN | Q86VV8 | 390 |
| CCDC178 | PHGR1 | C9JFL3 | 374 |
| CCDC178 | CCDC69 | A6NI79 | 369 |
| CCDC178 | SPDYC | Q5MJ68 | 366 |
| CCDC178 | CCDC88A | Q3V6T2 | 357 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCDC178 | HNRNPU | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (6): CCDC178 (Proximity Label-MS), CCDC178 (Positive Genetic), HNRNPA2B1 (Cross-Linking-MS (XL-MS)), EEA1 (Cross-Linking-MS (XL-MS)), CHTOP (Cross-Linking-MS (XL-MS)), IGF2BP1 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A2A2Z9, A6NC57, A8MYB1, A9JSR5, A9ZSY0, D3ZNV2, E9PVB3, O94252, P0A1K3, P0A1K4, P0C221, P0C7W6, Q01649, Q08B20, Q0VBY1, Q10006, Q10221, Q1MTQ0, Q2T9Z6, Q2TA00, Q2YDH9, Q3KPU6, Q5AI71, Q5BJE1, Q5I0J4, Q5PQJ9, Q5T0U0, Q5VUR7, Q66HB6, Q6AXT4, Q6AY08, Q6GM07, Q80X59, Q810N9, Q8BVM7, Q8BVN0, Q8CDV0, Q8IVF6, Q8IWF9, Q8N6Q1
Diamond homologs: Q5BJE1, Q8CDV0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
141 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 113 |
| Likely benign | 18 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4596 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:32974542:CCTA:C | donor_loss | 1.0000 |
| 18:32974543:CTA:C | donor_loss | 1.0000 |
| 18:32974544:TACCT:T | donor_loss | 1.0000 |
| 18:32974545:A:T | donor_loss | 1.0000 |
| 18:32974546:CC:C | donor_loss | 1.0000 |
| 18:32974575:T:A | donor_gain | 1.0000 |
| 18:32974677:CAGAG:C | acceptor_gain | 1.0000 |
| 18:32974682:C:CC | acceptor_gain | 1.0000 |
| 18:33215544:ACTT:A | donor_loss | 1.0000 |
| 18:33215545:CTT:C | donor_loss | 1.0000 |
| 18:33215545:CTTA:C | donor_gain | 1.0000 |
| 18:33215546:TTAC:T | donor_loss | 1.0000 |
| 18:33215547:TACT:T | donor_loss | 1.0000 |
| 18:33215548:A:AC | donor_gain | 1.0000 |
| 18:33215549:C:CT | donor_gain | 1.0000 |
| 18:33215549:CT:C | donor_gain | 1.0000 |
| 18:33215549:CTT:C | donor_gain | 1.0000 |
| 18:33215549:CTTT:C | donor_gain | 1.0000 |
| 18:33215549:CTTTA:C | donor_gain | 1.0000 |
| 18:33215691:TTACT:T | acceptor_gain | 1.0000 |
| 18:33215692:TACT:T | acceptor_gain | 1.0000 |
| 18:33215696:C:CC | acceptor_gain | 1.0000 |
| 18:33224773:A:AC | donor_gain | 1.0000 |
| 18:33224774:C:CC | donor_gain | 1.0000 |
| 18:33224774:CA:C | donor_gain | 1.0000 |
| 18:33224774:CAA:C | donor_gain | 1.0000 |
| 18:33224942:A:T | acceptor_gain | 1.0000 |
| 18:33226855:CCTA:C | acceptor_gain | 1.0000 |
| 18:33245262:CTT:C | donor_gain | 1.0000 |
| 18:33245427:TG:T | acceptor_gain | 1.0000 |
AlphaMissense
5826 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:33346327:C:G | R181P | 0.978 |
| 18:33346319:C:G | A184P | 0.977 |
| 18:32974671:A:G | L800P | 0.969 |
| 18:33346339:A:G | L177P | 0.955 |
| 18:33346351:A:G | L173P | 0.951 |
| 18:33346240:A:G | L210P | 0.948 |
| 18:33212018:C:G | A706P | 0.943 |
| 18:33346215:C:A | Q218H | 0.935 |
| 18:33346215:C:G | Q218H | 0.935 |
| 18:33346219:A:T | V217E | 0.935 |
| 18:33346325:C:G | A182P | 0.930 |
| 18:33346216:T:G | Q218P | 0.928 |
| 18:33346310:C:G | A187P | 0.928 |
| 18:33211920:T:A | R738S | 0.925 |
| 18:33211920:T:G | R738S | 0.925 |
| 18:33370143:G:C | S85R | 0.925 |
| 18:33370143:G:T | S85R | 0.925 |
| 18:33370145:T:G | S85R | 0.925 |
| 18:33346361:C:G | A170P | 0.924 |
| 18:33245354:A:G | L495P | 0.922 |
| 18:33092871:C:G | A760P | 0.921 |
| 18:32974680:A:G | L797P | 0.919 |
| 18:33267030:A:G | L432P | 0.919 |
| 18:33293169:A:G | L389P | 0.918 |
| 18:33346223:C:G | A216P | 0.918 |
| 18:33346256:A:G | W205R | 0.915 |
| 18:33346256:A:T | W205R | 0.915 |
| 18:33212004:A:C | F710L | 0.912 |
| 18:33212004:A:T | F710L | 0.912 |
| 18:33212006:A:G | F710L | 0.912 |
dbSNP variants (sampled 300 via entrez): RS1000001512 (18:33132567 A>C), RS1000011197 (18:32994974 T>C), RS1000021691 (18:33286817 T>C), RS1000028427 (18:33011716 G>A), RS1000028476 (18:33382290 C>T), RS1000038821 (18:33224743 C>T), RS1000040892 (18:33098591 T>C), RS1000045099 (18:33049014 A>G), RS1000048813 (18:33014262 G>A), RS1000061650 (18:33272655 T>C), RS1000062175 (18:33230981 G>A), RS1000069655 (18:33373705 C>T), RS1000072214 (18:33329886 T>A), RS1000078648 (18:33233859 C>T), RS1000079127 (18:33195941 T>C)
Disease associations
OMIM: gene MIM:621139 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002119_3 | Metabolite levels (X-11787) | 9.000000e-06 |
| GCST002875_51 | Diisocyanate-induced asthma | 5.000000e-06 |
| GCST003264_499 | Post bronchodilator FEV1/FVC ratio | 3.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005276 | hydroxy-leucine measurement |
| EFO:0006995 | response to diisocyanate |
| EFO:0004713 | FEV/FVC ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression, increases methylation | 4 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| bisphenol A | affects methylation | 1 |
| sodium arsenite | increases expression | 1 |
| tobacco tar | decreases reaction, increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| diallyl disulfide | decreases reaction, increases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| MT19c compound | decreases expression | 1 |
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Arsenic | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Copper | decreases expression, affects cotreatment | 1 |
| Methapyrilene | decreases methylation | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.